查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553963

静脉曲张治疗市场规模、份额和趋势分析报告：按类型、最终用途、地区和细分市场预测，2024-2030 年

Varicose Veins Treatment Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Injection Sclerotherapy), By End-use (Specialty Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

静脉曲张治疗市场的成长与趋势：

Grand View Research I am 的最新报告显示，到 2030 年，全球静脉曲张治疗市场规模预计将达到 20.8 亿美元，2024 年至 2030 年复合年增长率预计为 6.4%。

技术进步的不断进步，加上先进静脉曲张治疗设备的可用性增加以及向微创手术的转变是推动市场成长的因素。

欧洲和北美血管疾病的高负担、患者依从性和信心的提高、医疗保健支出的增加以及老年人口的迅速增加是静脉曲张治疗市场的主要驱动力。

肥胖、睡眠障碍、血压水平升高、荷尔蒙变化、遗传性疾病以及妊娠等文明病的盛行率增加是导致周边血管疾病的一些主要因素。未经治疗的静脉功能不全，例如静脉曲张和静脉溃疡，会导致进行进行性综合征，包括慢性静脉功能不全。 2015 年，根据 FutSci 报导，慢性静脉功能不全是一种广泛存在的社会孤立性疾病，会导致成年人患病。它是世界上最常见的疾病，估计影响西方国家 5% 的人口。

静脉曲张治疗市场报告亮点：

  • 硬化疗法因其切口小、疤痕少等优点而被公认为最盈利的治疗方法。此外，诸如增加渗透性、成本和时间效率、降低周围组织附带损伤的风险、减少术后併发症以及无痛手术等优点也促进了该细分市场的成长。
  • 静脉消融治疗领域因其治疗时间短、术后血液循环改善等优点预计将成为成长最快的领域。由于副作用最小化、潜在的成本节省和更好的患者治疗效果，ClosureFast 技术在静脉消融治疗领域的发展势头越来越强劲。
  • 静脉化学消融或化学硬化疗法是消融疗法中使用最广泛的医疗程序。硬化疗法、强烈脉衝光疗法、雷射消熔、射频和门诊静脉曲张切除术是较新的技术，由于侵入性较小，因此使用更频繁。
  • 由于该地区人口中静脉曲张和蜘蛛网状静脉曲张的盛行率不断上升、有利的报销政策、医疗保健意识的提高、政府支出以及美容意识的提高，到 2023 年，北美将占据最大的市场占有率。
  • 由于医疗基础设施改善、患者对静脉曲张早期治疗益处的意识层级不断提高以及可支配收入增加等因素，亚太地区预计将出现最快的增长。
  • 市场主要企业包括 Quanta Systems SpA、Vascular Solutions, Inc.、Eufoton SRL、Energist Group、Medtronic plc、Dornier MedTech GmbH、Lumenis Ltd.、Syneron Medical Ltd.、Biolitec AG、AngioDynamics, Inc.。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章静脉曲张治疗市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 静脉曲张治疗市场分析工具
    • 波特的分析
    • PESTEL分析

第四章下肢静脉曲张治疗市场：按类型估计和趋势分析

  • 细分仪表板
  • 静脉曲张治疗市场：类型变化分析，2023 年和 2030 年
  • 静脉内消融（EVLA）
  • 注射硬化疗法
  • 手术结扎/剥离

第五章下肢静脉曲张治疗市场：依最终用途分类的估计与趋势分析

  • 细分仪表板
  • 静脉曲张治疗市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 门诊手术中心
  • 专科诊所

第六章 下肢静脉曲张治疗市场：区域估计与趋势分析

  • 2023 年及 2030 年静脉曲张治疗市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Medtronic
    • Lumenis Be Ltd.
    • AngioDynamics
    • Sciton
    • Quanta System
    • intros Medical Laser GmbH
    • Alma lasers
    • Dornier MedTech
    • Theraclion
简介目录
Product Code: 978-1-68038-963-0

Varicose Veins Treatment Market Growth & Trends:

The global varicose veins treatment market size is expected to reach USD 2.08 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.

Varicose Veins Treatment Market Report Highlights:

  • The sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
  • The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segment has gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
  • The endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
  • In 2023, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
  • The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
  • Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Varicose Veins Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Varicose Veins Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Varicose Veins Treatment Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Varicose Veins Treatment Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Endovenous Ablation (EVLA)
    • 4.3.1. Endovenous Ablation (EVLA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Radiofrequency Ablation
      • 4.3.2.1. Radiofrequency Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Laser Ablation
      • 4.3.3.1. Laser Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Injection Sclerotherapy
    • 4.4.1. Injection Sclerotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Surgical Ligation/Stripping
    • 4.5.1. Surgical Ligation/Stripping Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Varicose Veins Treatment Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Varicose Veins Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Varicose Veins Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Varicose Veins Treatment Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. South Korea Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Lumenis Be Ltd.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. AngioDynamics
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Sciton
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Quanta System
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. intros Medical Laser GmbH
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Alma lasers
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Dornier MedTech
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Theraclion
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives